Literature DB >> 28992360

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains.

Frédéric Le Gal1,2, Ségolène Brichler1,2,3, Tudor Drugan4, Chakib Alloui1,2, Dominique Roulot2,5, Jean-Michel Pawlotsky3,6, Paul Dény1,7, Emmanuel Gordien1,2,3.   

Abstract

Hepatitis delta virus (HDV) is responsible for the most severe form of acute and chronic viral hepatitis. We previously proposed that the Deltavirus genus is composed of eight major clades. However, few sequences were available to confirm this classification. Moreover, little is known about the structural and functional consequences of HDV variability. One practical consequence is the failure of most quantification assays to properly detect or quantify plasmatic HDV RNA. Between 2001 and 2014, 2,152 HDV strains were prospectively collected and genotyped in our reference laboratory by means of nucleotide sequencing and extensive phylogenetic analyses of a 400-nucleotide region of the genome (R0) from nucleotides 889 to 1289 encompassing the 3' end of the delta protein-coding gene. In addition, the full-length genome sequence was generated for 116 strains selected from the different clusters, allowing for in-depth characterization of the HDV genotypes and subgenotypes. This study confirms that the HDV genus is composed of eight genotypes (HDV-1 to HDV-8) defined by an intergenotype similarity >85% or >80%, according to the partial or full-length genome sequence, respectively. Furthermore, genotypes can be segregated into two to four subgenotypes, characterized by an intersubgenotype similarity >90% (>84% for HDV-1) over the whole genome sequence. Systematic analysis of genome and protein sequences revealed highly conserved functional nucleotide and amino acid motifs and positions across all (sub)genotypes, indicating strong conservatory constraints on the structure and function of the genome and the protein.
CONCLUSION: This study provides insight into the genetic diversity of HDV and a clear view of its geographical localization and allows speculation as to the worldwide spread of the virus, very likely from an initial African origin. (Hepatology 2017;66:1826-1841).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28992360     DOI: 10.1002/hep.29574

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  31 in total

Review 1.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 2.  Pathogenesis of and New Therapies for Hepatitis D.

Authors:  Christopher Koh; Theo Heller; Jeffrey S Glenn
Journal:  Gastroenterology       Date:  2018-10-18       Impact factor: 22.682

Review 3.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

4.  HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.

Authors:  Luna Colagrossi; Romina Salpini; Rossana Scutari; Luca Carioti; Arianna Battisti; Lorenzo Piermatteo; Ada Bertoli; Lavinia Fabeni; Carmine Minichini; Pascale Trimoulet; Hervé Fleury; Elena Nebuloso; Maria De Cristofaro; Giuseppina Cappiello; Alberto Spanò; Vincenzo Malagnino; Terenzio Mari; Angelo Barlattani; Nerio Iapadre; Miriam Lichtner; Claudio Mastroianni; Ilaria Lenci; Caterina Pasquazzi; Giuseppe Maria De Sanctis; Alfonso Galeota Lanza; Maria Stanzione; Gianfranca Stornaiuolo; Massimo Marignani; Loredana Sarmati; Massimo Andreoni; Mario Angelico; Francesca Ceccherini-Silberstein; Carlo-Federico Perno; Nicola Coppola; Valentina Svicher
Journal:  Viruses       Date:  2018-07-09       Impact factor: 5.048

5.  Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients.

Authors:  Laura Scheller; Gudrun Hilgard; Olympia Anastasiou; Ulf Dittmer; Alisan Kahraman; Heiner Wedemeyer; Katja Deterding
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

6.  Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice.

Authors:  Katja Giersch; Lennart Hermanussen; Tassilo Volz; Annika Volmari; Lena Allweiss; Camille Sureau; John Casey; Jiabin Huang; Nicole Fischer; Marc Lütgehetmann; Maura Dandri
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

Review 7.  Hepatitis delta virus: From infection to new therapeutic strategies.

Authors:  Grazia A Niro; Arianna Ferro; Francesca Cicerchia; Isabella Brascugli; Marilena Durazzo
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

8.  High prevalence of hepatitis delta virus in Cameroon.

Authors:  Emily K Butler; Mary A Rodgers; Kelly E Coller; Devin Barnaby; Elizabeth Krilich; Ana Olivo; Michael Cassidy; Dora Mbanya; Lazare Kaptue; Nicaise Ndembi; Gavin Cloherty
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

9.  Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults.

Authors:  Narcisse Patrice Komas; Sumantra Ghosh; Mariama Abdou-Chekaraou; Pierre Pradat; Nasser Al Hawajri; Alexandre Manirakiza; Gina Laure Laghoe; Claudine Bekondi; Ségolène Brichler; Jean-Omer Ouavéné; Abdoulaye Sépou; Brice Martial Yambiyo; Jean Chrysostome Gody; Valentin Fikouma; Athénais Gerber; Natali Abeywickrama Samarakoon; Dulce Alfaiate; Caroline Scholtès; Nora Martel; Frédéric Le Gal; Hugo Lo Pinto; Ikram Amri; Olivier Hantz; David Durantel; Jean-Louis Lesbordes; Emmanuel Gordien; Philippe Merle; Tudor Drugan; Christian Trépo; Fabien Zoulim; Jean-Claude Cortay; Alan Campbell Kay; Paul Dény
Journal:  PLoS Negl Trop Dis       Date:  2018-04-26

Review 10.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.

Authors:  Stephan Urban; Christoph Neumann-Haefelin; Pietro Lampertico
Journal:  Gut       Date:  2021-06-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.